Explore 3 Stock Ideas & Industry Insights Download Free Report

888-969-2592
Shopping Cart 0
countryflagCA
Login

Home CompaniesSi-Bone Inc

Si-Bone Inc

Healthcare Medical Devices
PortfolioPortfolio WatchlistWatchlist
Company price
23.725 USD 3.50 ( 17.33%)
Last update at 2026-11-03T20:56:00Z
VOLUME
2888209
Market Cap
843.34M

Momentum Score

…

SI-BONE, Inc., a medical device company, focuses on solving musculoskeletal disorders of the sacropelvic anatomy in the United States and internationally. The company offers proprietary minimally invasive surgical implant systems to address sacroiliac joint dysfunction and degeneration, adult deformity and degeneration, and pelvic trauma, as well as implantable bone products. It also provides iFuse-3D, a titanium implant that combines the triangular cross-section of the iFuse implant with a proprietary 3D-printed porous surface and fenestrated design; iFuse TORQ, a line of 3D-printed threaded implants designed for applications in pelvic trauma and sacroliliac fusion; and iFuse Bedrock Granite Implant System that provides sacroiliac fusion and sacropelvic fixation as a foundational element for segmental spinal fusion; and iFuse TORQ TNT to treat pelvic trauma and sacroiliac joint dysfunction, as well as iFuse INTRA implants that are marketed as human cells, tissues, and cellular or tissue-based products. The company markets its products primarily with a direct sales force, as well as through third-party sales agent and resellers. SI-BONE, Inc. was incorporated in 2008 and is headquartered in Santa Clara, California.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
19.07
Low
23.93
High
52 Week Price Range
11.70
Low
20.05
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High
AI Summary

Si-Bone develops minimally invasive implants and surgical instruments to treat sacroiliac (SI) joint dysfunction. Long-term growth could be supported by demographic aging, higher diagnosis and referral rates, rising surgeon adoption and international expansion. The company may appeal to investors seeking exposure to a focused, procedure-driven medtech business with potential for recurring revenue as procedure volumes scale.

Key risks are dependence on a narrow product and procedure set, reimbursement and procedure-volume variability, competition from other spine device makers, and regulatory or litigation events that could constrain market access.

Risk Score
Medium

Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.

Key Metrics*

Previous Close
20.22
Dividend Yield
-
Revenue TTM
176.60M
Revenue Per Share
4.22
Gross Profit TTM
139.95M
Debt / Equity
0.22
ROE
-15.96%
Net Debt
2.54M
ROCE
-29.32%
Diluted EPS TTM
-0.63

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Income before tax -61.26M -56.57M -43.70M -38.40M -17.45M
Net income -62.90M -60.13M -48.54M -42.58M -17.45M
Selling general administrative 28.96M 25.07M 19.80M 20.98M 12.64M
Selling and marketing expenses 107.73M 93.88M 73.79M 68.25M 44.50M
Gross profit 90.70M 79.72M 64.48M 60.51M 50.55M
Reconciled depreciation 3.45M 2.09M 1.13M 0.77M 0.72M
Ebit -59.61M -51.67M -38.57M -36.00M -12.69M
Ebitda -58.44M -51.21M -37.60M -33.45M -11.96M
Depreciation and amortization 1.17M 0.46M 0.97M 2.55M 0.72M
Non operating income net other 1.17M - 0.97M 2.55M -0.38M
Operating income -59.61M -51.67M -38.57M -36.00M -11.96M
Other operating expenses 166.02M 141.82M 111.95M 103.30M 67.34M
Interest expense 2.82M 5.37M 6.10M 4.95M 5.49M
Interest income 1.30M 0.19M 1.10M 2.55M 0.77M
Net interest income -1.51M -5.18M -5.00M -2.40M -4.34M
Income tax expense 1.65M 3.56M 4.84M 4.17M 5.49M
Total revenue 106.41M 90.15M 73.39M 67.30M 55.38M
Total operating expenses 150.31M 131.39M 103.05M 96.51M 62.51M
Cost of revenue 15.71M 10.43M 8.90M 6.79M 4.83M
Total other income expense net -1.65M -4.90M -5.13M -2.40M -1.15M
Net income from continuing ops -61.26M -56.57M -43.70M -38.40M -17.45M
Net income applicable to common shares -61.26M -56.57M -43.70M -38.40M -17.45M
Breakdown 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Type yearly yearly yearly yearly yearly
Date 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Total assets 230.44M 230.43M 157.55M 190.51M 223.14M
Other current assets 3.20M 3.17M 2.37M 3.14M 2.56M
Total liab 63.47M 61.05M 59.25M 56.09M 53.78M
Total stockholder equity 166.96M 169.38M 98.30M 134.42M 169.36M
Other current liab 19.49M 17.45M 13.51M 1.30M 10.20M
Common stock 0.00M 0.00M 455.18M 429.92M 408.12M
Capital stock 0.00M 0.00M 455.18M 0.00M 0.00M
Retained earnings -431.35M -400.44M -357.11M -295.85M -239.28M
Other liab - - 0.03M 0.06M 0.85M
Other assets - - 0.38M 0.40M 0.37M
Cash 34.95M 33.27M 20.72M 63.42M 53.58M
Total current liabilities 27.13M 23.46M 21.18M 16.89M 13.47M
Current deferred revenue - - - 11.05M -
Net debt 2.54M 5.72M 18.71M -22.94M -14.13M
Short term debt 1.15M 1.42M 1.39M 1.34M -
Short long term debt total 37.48M 38.99M 39.43M 40.48M 39.45M
Other stockholder equity 598.07M 569.48M 455.17M 429.91M 408.11M
Property plant equipment - - 15.56M 14.24M 4.53M
Total current assets 207.78M 211.39M 137.61M 175.87M 218.24M
Long term investments - - - - 0.00M
Net tangible assets - - 98.30M 134.42M 169.36M
Short term investments 115.09M 132.75M 76.57M 83.56M 142.85M
Net receivables 27.46M 21.95M 20.67M 14.25M 13.61M
Long term debt 35.45M 36.06M 35.17M 34.97M 39.45M
Inventory 27.07M 20.25M 17.28M 11.50M 5.63M
Accounts payable 6.49M 4.59M 6.28M 3.20M 3.27M
Accumulated other comprehensive income 0.24M 0.34M 0.23M 0.35M 0.52M
Common stock total equity - - 0.00M - 0.00M
Retained earnings total equity - - -357.11M - -239.28M
Non currrent assets other 0.30M 0.33M 0.38M 0.40M 0.37M
Non current assets total 22.66M 19.03M 19.94M 14.64M 4.90M
Capital lease obligations 2.03M 2.93M 4.26M 5.50M -
Long term debt total - - 35.17M - 39.45M
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Investments 6.69M 57.97M -60.35M 15.94M -96.88M
Change to liabilities 3.74M -0.53M 0.07M 5.38M 1.51M
Total cashflows from investing activities -2.81M 51.58M -62.92M 13.49M -97.83M
Net borrowings - -6.00M -1.59M -6.00M -6.00M
Total cash from financing activities 2.20M -1.71M 136.40M 3.49M 115.15M
Change to operating activities 2.02M 1.13M -0.90M 4.48M 0.51M
Net income -61.26M -56.57M -43.70M -38.40M -17.45M
Change in cash -42.70M 9.84M 43.15M -14.69M 2.71M
Begin period cash flow 63.42M 53.58M 10.44M 25.12M 22.41M
End period cash flow 20.72M 63.42M 53.58M 10.44M 25.12M
Total cash from operating activities -41.66M -39.53M -30.66M -31.63M -14.52M
Issuance of capital stock - 0.00M 134.62M 0.00M 115.51M
Depreciation 3.45M 2.09M 1.13M 0.77M 0.72M
Other cashflows from investing activities - - - 15.94M -96.88M
Dividends paid - - -1.92M - -
Change to inventory -5.71M -5.78M -0.27M -2.10M -0.76M
Change to account receivables -6.48M -0.57M -2.19M -3.24M -1.02M
Sale purchase of stock 1.82M 2.34M 1.92M 2.20M -0.07M
Other cashflows from financing activities -2.81M 36.95M 47.08M 1.28M -0.28M
Change to netincome 23.36M 20.42M 14.03M 7.63M 3.19M
Capital expenditures 9.51M 6.39M 2.56M 2.44M 0.94M
Change receivables -6.48M - -2.19M -3.24M -1.02M
Cash flows other operating 0.81M - -0.14M -0.52M -0.75M
Exchange rate changes - - - - -0.09M
Cash and cash equivalents changes -42.27M - 42.82M -14.65M 2.71M
Change in working capital -7.64M -5.76M -2.53M -0.48M -1.02M
Stock based compensation 23.06M 16.87M 11.93M 7.46M 2.31M
Other non cash items 0.73M 0.29M 0.29M 0.26M 0.26M
Free cash flow -51.16M -45.92M -33.22M -34.07M -15.46M

Peer Comparison*

Sector: Healthcare Industry: Medical Devices

Stock Name
Change
(USD)
Price
(USD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
SIBN
Si-Bone Inc		 3.50
17.33%		 23.73 - - 4.78 5.04 4.17 -14.15
ABT
Abbott Laboratories		 -
-%		 109.40 25.97 17.24 3.57 3.20 3.81 16.75
MDT
Medtronic PLC		 -0.41
0.41%		 98.88 26.60 15.87 3.35 2.08 3.90 14.12
SYK
Stryker Corporation		 3.74
1.22%		 310.55 29.23 16.86 4.18 4.51 4.63 17.16
SEMHF
Siemens Healthineers AG		 0.66
1.38%		 48.35 39.57 21.32 3.01 3.29 2.95 16.92

Profile*

Si-Bone Inc

SI-BONE, Inc., a medical device company, focuses on solving musculoskeletal disorders of the sacropelvic anatomy in the United States and internationally. The company offers proprietary minimally invasive surgical implant systems to address sacroiliac joint dysfunction and degeneration, adult deformity and degeneration, and pelvic trauma, as well as implantable bone products. It also provides iFuse-3D, a titanium implant that combines the triangular cross-section of the iFuse implant with a proprietary 3D-printed porous surface and fenestrated design; iFuse TORQ, a line of 3D-printed threaded implants designed for applications in pelvic trauma and sacroliliac fusion; and iFuse Bedrock Granite Implant System that provides sacroiliac fusion and sacropelvic fixation as a foundational element for segmental spinal fusion; and iFuse TORQ TNT to treat pelvic trauma and sacroiliac joint dysfunction, as well as iFuse INTRA implants that are marketed as human cells, tissues, and cellular or tissue-based products. The company markets its products primarily with a direct sales force, as well as through third-party sales agent and resellers. SI-BONE, Inc. was incorporated in 2008 and is headquartered in Santa Clara, California.

471 El Camino Real, Santa Clara, CA, United States, 95050

408 207 0700

https://si-bone.com

349

Name Title Year Born
Ms. Laura A. Francis MBA CEO & Director 1967
Mr. Anshul Maheshwari Chief Financial Officer 1978
Mr. Anthony J. Recupero Pres of Commercial Operations 1959
Mr. Michael A. Pisetsky Sr. VP of Operations & Admin., Sec. and Chief Legal Officer 1978
Mr. Jeff Bertolini Sr. VP of Operations & Information Technology NA
Dr. Scott A. Yerby Sr. VP of Engineering & CTO 1968
Mr. Joseph W. Powers VP of Corp. Marketing 1960
Ms. Aimee Einstein VP of People & Culture NA
Dr. Daniel Joseph Cher Sr. VP of Clinical & Regulatory Affairs 1965
Dr. W. Carlton Reckling Chief Medical Officer & VP of Medical Affairs 1962

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Kalkine

3 Mining Stock
Ideas Report

Download a free report with stock ideas and industry insights for general information.

Download Free Report Now → sector image

Top Stocks by Market Cap*

VNP
CAD 32.54
+24.44%
HUT
CAD 88.32
+14.81%
KEEL
CAD 3.05
+14.66%
MTY
CAD 36.63
+13.58%
CNL
CAD 15.98
+11.90%
MOON
CAD 4.72
-12.34%
EU
CAD 0.96
-8.57%
URE
CAD 1.02
-8.48%
AP-UN
CAD 3.71
-8.17%
HG
CAD 3.77
-8.05%

Equity Sectors*

  • Basic Materials

    -1.14%

  • Communication Services

    +0.65%

  • Consumer Cyclical

    +0.09%

  • Consumer Defensive

    -0.57%

  • Energy

    -0.15%

  • Financial Services

    +0.08%

  • Healthcare

    +2.18%

  • Industrials

    +2.04%

  • Real Estate

    -0.25%

  • Technology

    +1.02%

  • Utilities

    +0.66%

Note: Daily price change (%) by sector excluding stocks with +/-90% daily price change. Companies above $500 million market capitalization are considered.

Support

Hi! How can we help you today?

Loading…